Steen Jakobsen1, Morten Busk2, Jonas Brorson Jensen3, Ole Lajord Munk4, Nora Elisabeth Zois4, Aage K O Alstrup4, Niels Jessen5, Jørgen Frøkiær4. 1. PET Center, Aarhus University Hospital, Aarhus, Denmark jakobsen.steen@gmail.com. 2. Department of Experimental Oncology, Aarhus University Hospital, Aarhus, Denmark; and. 3. PET Center, Aarhus University Hospital, Aarhus, Denmark Department of Clinical Medicine, Aarhus University, Denmark. 4. PET Center, Aarhus University Hospital, Aarhus, Denmark. 5. Department of Clinical Medicine, Aarhus University, Denmark.
Abstract
UNLABELLED: Organic cation transporters (OCTs) in the kidney proximal tubule (PT) participate in renal excretion of drugs and endogenous compounds. PT function is commonly impaired in kidney diseases, and consequently quantitative measurement of OCT function may provide an important estimate of kidney function. Metformin is a widely used drug and targets OCT type 2 located in the PT. Thus, we hypothesized that (11)C-labeled metformin would be a suitable PET tracer for quantification of renal function. METHODS: (11)C-metformin was prepared by (11)C-methylation of 1-methylbiguanide. In vitro cell uptake of (11)C-metformin was studied in LLC-PK1 cells in the presence of increasing doses of unlabeled metformin. In vivo small-animal PET studies in Sprague-Dawley rats were performed at baseline and after treatment with OCT inhibitors to evaluate renal uptake of (11)C-metformin. Kidney and liver pharmacokinetics of (11)C-metformin was investigated in vivo by dynamic (11)C-metformin PET/CT in 6 anesthetized pigs, and renal clearance of (11)C-metformin was compared with renal clearance of (51)Cr-ethylenediaminetetraacetic acid (EDTA). Formation of (11)C metabolites was investigated by analysis of blood and urine samples. RESULTS: The radiochemical yield of (11)C-metformin was 15% ± 3% (n= 40, decay-corrected), and up to 1.5 GBq of tracer were produced with a radiochemical purity greater than 95% in less than 30 min. Dose-dependent uptake of (11)C-metformin in LLC-PK1 cells was rapid. Rat small-animal PET images showed (11)C-metformin uptake in the kidney and liver, the kinetics of which were changed after challenging animals with OCT inhibitors. In pigs, 80% of the injected metformin dose was rapidly present in the kidney, and a high dose of metformin caused a delayed renal uptake and clearance compared with baseline consistent with transporter-mediated competition. Renal clearance of (11)C-metformin was approximately 3 times the renal clearance of (51)Cr-EDTA. CONCLUSION: We successfully synthesized an (11)C-metformin tracer, and PET studies in rats and pigs showed a rapid kidney uptake from the blood and excretion into the bladder similar to other radiopharmaceuticals developed for γ-camera renography.
UNLABELLED: Organic cation transporters (OCTs) in the kidney proximal tubule (PT) participate in renal excretion of drugs and endogenous compounds. PT function is commonly impaired in kidney diseases, and consequently quantitative measurement of OCT function may provide an important estimate of kidney function. Metformin is a widely used drug and targets OCT type 2 located in the PT. Thus, we hypothesized that (11)C-labeled metformin would be a suitable PET tracer for quantification of renal function. METHODS:(11)C-metformin was prepared by (11)C-methylation of 1-methylbiguanide. In vitro cell uptake of (11)C-metformin was studied in LLC-PK1 cells in the presence of increasing doses of unlabeled metformin. In vivo small-animal PET studies in Sprague-Dawley rats were performed at baseline and after treatment with OCT inhibitors to evaluate renal uptake of (11)C-metformin. Kidney and liver pharmacokinetics of (11)C-metformin was investigated in vivo by dynamic (11)C-metformin PET/CT in 6 anesthetized pigs, and renal clearance of (11)C-metformin was compared with renal clearance of (51)Cr-ethylenediaminetetraacetic acid (EDTA). Formation of (11)C metabolites was investigated by analysis of blood and urine samples. RESULTS: The radiochemical yield of (11)C-metformin was 15% ± 3% (n= 40, decay-corrected), and up to 1.5 GBq of tracer were produced with a radiochemical purity greater than 95% in less than 30 min. Dose-dependent uptake of (11)C-metformin in LLC-PK1 cells was rapid. Rat small-animal PET images showed (11)C-metformin uptake in the kidney and liver, the kinetics of which were changed after challenging animals with OCT inhibitors. In pigs, 80% of the injected metformin dose was rapidly present in the kidney, and a high dose of metformin caused a delayed renal uptake and clearance compared with baseline consistent with transporter-mediated competition. Renal clearance of (11)C-metformin was approximately 3 times the renal clearance of (51)Cr-EDTA. CONCLUSION: We successfully synthesized an (11)C-metformin tracer, and PET studies in rats and pigs showed a rapid kidney uptake from the blood and excretion into the bladder similar to other radiopharmaceuticals developed for γ-camera renography.
Authors: Elias Immanuel Ordell Sundelin; Lars Christian Gormsen; Sara Heebøll; Mikkel Holm Vendelbo; Steen Jakobsen; Ole Lajord Munk; Søren Feddersen; Kim Brøsen; Stephen Jacques Hamilton-Dutoit; Steen Bønløkke Pedersen; Henning Grønbaek; Niels Jessen Journal: Br J Clin Pharmacol Date: 2019-06-18 Impact factor: 4.335
Authors: Elias Immanuel Ordell Sundelin; Nidal Al-Suliman; Pernille Vahl; Mikkel Vendelbo; Ole Lajord Munk; Steen Jakobsen; Steen Bønløkke Pedersen; Jørgen Frøkiær; Lars C Gormsen; Niels Jessen Journal: Breast Cancer Res Treat Date: 2020-04-02 Impact factor: 4.872
Authors: Michael Christensen; Jonas B Jensen; Steen Jakobsen; Niels Jessen; Jørgen Frøkiær; Bruce E Kemp; Allison L Marciszyn; Hui Li; Núria M Pastor-Soler; Kenneth R Hallows; Rikke Nørregaard Journal: Sci Rep Date: 2016-10-26 Impact factor: 4.379
Authors: Roger W Hunter; Curtis C Hughey; Louise Lantier; Elias I Sundelin; Mark Peggie; Elton Zeqiraj; Frank Sicheri; Niels Jessen; David H Wasserman; Kei Sakamoto Journal: Nat Med Date: 2018-08-27 Impact factor: 53.440
Authors: Diana Brickute; Marta Braga; Maciej A Kaliszczak; Chris Barnes; Doreen Lau; Laurence Carroll; Elizabeth Stevens; Sebastian Trousil; Israt S Alam; Quang-Dé Nguyen; Eric O Aboagye Journal: Mol Pharm Date: 2019-04-03 Impact factor: 4.939